202 related articles for article (PubMed ID: 11965826)
1. Dyslipidaemia and coagulation defects of insulin resistance.
Frohlich J; Steiner G
Int J Clin Pract Suppl; 2000 Oct; (113):14-22. PubMed ID: 11965826
[TBL] [Abstract][Full Text] [Related]
2. Management of hypercholesterolaemia in the patient with diabetes.
Packard C; Olsson AG
Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
[TBL] [Abstract][Full Text] [Related]
3. [Dyslipidemia in diabetes mellitus].
Niemeijer-Kanters SD; Banga JD; Erkelens DW
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
[TBL] [Abstract][Full Text] [Related]
4. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
6. Prevention of coronary heart disease in type 2 diabetes.
Mykkänen L
Int J Clin Pract Suppl; 2000 Oct; (113):40-5. PubMed ID: 11965831
[TBL] [Abstract][Full Text] [Related]
7. Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes?
Shepherd J
Atheroscler Suppl; 2005 Sep; 6(3):15-9. PubMed ID: 16046280
[TBL] [Abstract][Full Text] [Related]
8. Diabetic dyslipidaemia.
Erkelens DW
Eur Heart J; 1998 Jul; 19 Suppl H():H27-40. PubMed ID: 9717062
[TBL] [Abstract][Full Text] [Related]
9. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.
Steinmetz A
Diabetes Metab Res Rev; 2008; 24(4):286-93. PubMed ID: 18273835
[TBL] [Abstract][Full Text] [Related]
10. Gemfibrozil treatment increases low-density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizability.
O'Neal DN; O'Brien RC; Timmins KL; Grieve GD; Lau KP; Nicholson GC; Kotowicz MA; Best JD
Diabet Med; 1998 Oct; 15(10):870-7. PubMed ID: 9796889
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of cardiovascular disease in type 2 diabetes.
Serrano Rios M
Int J Clin Pract Suppl; 2001 Sep; (121):4-7. PubMed ID: 11594245
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidaemia in diabetic patients: time for a rethink.
Shepherd J
Diabetes Obes Metab; 2007 Sep; 9(5):609-16. PubMed ID: 17697054
[TBL] [Abstract][Full Text] [Related]
13. Lipids in type 2 diabetes.
Laakso M
Semin Vasc Med; 2002 Feb; 2(1):59-66. PubMed ID: 16222596
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
15. What is the most effective strategy for managing diabetic dyslipidaemia?
Reasner CA
Atheroscler Suppl; 2005 Sep; 6(3):21-7. PubMed ID: 16054442
[TBL] [Abstract][Full Text] [Related]
16. Treatment of diabetic dyslipoproteinemia.
Steinmetz A
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):239-45. PubMed ID: 12951627
[TBL] [Abstract][Full Text] [Related]
17. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
Temelkova-Kurktschiev T; Hanefeld M
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
[TBL] [Abstract][Full Text] [Related]
18. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.
Zareba W; Pancio G; Moss AJ; Kalaria VG; Marder VJ; Weiss HJ; Watelet LF; Sparks CE
Thromb Haemost; 2001 Sep; 86(3):791-9. PubMed ID: 11583309
[TBL] [Abstract][Full Text] [Related]
19. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
de Vries R; Borggreve SE; Dullaart RP
Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and cardiovascular risk markers.
Erdmann E
Curr Med Res Opin; 2005; 21 Suppl 1():S21-8. PubMed ID: 15811196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
